In particular, alterations in fibroblast growth factor receptor 4 (FGFR4) occur in breast, ovarian, prostate, colon, rhabdomyosarcoma, pancreatic, gastric, hepatocellular and pituitary adenocarcinomas [4–6, 8]. The gene discussed is FGFR4; the disease is pituitary adenocarcinoma.